Calculation of Platelet-rich Plasma Preparation Yield
NCT03161743 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2017-08-10
Summary
This is a study to determine 1) the consistency of platelet-rich plasma produced by several methods, and 2) whether the platelet content of platelet-rich plasma can be accurately estimated from a baseline CBC platelet count.
Conditions
- Platelet-rich Plasma Production
Interventions
- PROCEDURE
-
venipuncture
blood draw for the purpose of determining the platelet concentration in PRP
Sponsors & Collaborators
-
Harrison, Theodore, M.D.
lead INDIV
Principal Investigators
-
Theodore E Harrison · Theodore Harrison
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-06-30
- Primary Completion
- 2018-05-31
- Completion
- 2018-05-31
Countries
- Canada
Study Locations
More Related Trials
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 ·Status: RECRUITING ·Phase: NA
-
A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients
NCT03187652 ·Status: RECRUITING
-
Assessment of Whole Blood Cold Stored Platelets
NCT02006368 ·Status: COMPLETED ·Phase: NA
-
Unravelling the Role of Apoptosis in Platelets Biogenesis Through the Study of the Thrombocytopenia THC4
NCT07026578 ·Status: ACTIVE_NOT_RECRUITING
-
Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
NCT00117143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Italian Platelet Technology Assessment Study
NCT01642563 ·Status: TERMINATED ·Phase: PHASE3
-
The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)
NCT06291415 ·Status: WITHDRAWN ·Phase: PHASE1
-
Association of Platelet Parameters With Bleeding Severity in Children With ITP
NCT03810352 ·Status: COMPLETED
-
A Study of Prometic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia
NCT02690714 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Platelet Function With Various Storage Techniques
NCT03338660 ·Status: WITHDRAWN ·Phase: PHASE2
-
RP% Measurement by FCM as a Diagnostic Test for ITP
NCT02967328 ·Status: UNKNOWN
-
Effects of Long-term Dosing of AMG 531 on Bone Marrow Morphology
NCT00861224 ·Status: COMPLETED
-
The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients
NCT03951623 ·Status: COMPLETED ·Phase: PHASE1
-
Collection of Peripheral Blood From Patients With Hematologic Malignancies With Thrombocytopenia
NCT06824727 ·Status: COMPLETED
-
Pathogen Reduction Evaluation & Predictive Analytical Rating Score
NCT02783313 ·Status: COMPLETED ·Phase: NA
-
Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
NCT01727999 ·Status: COMPLETED
-
Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)
NCT06594146 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Randomized, Multi-center, Open-label, Paired Controlled, Crossover In Vivo Study
NCT02653443 ·Status: TERMINATED ·Phase: PHASE2
-
Platelet Reactivity In Patients With Nuisance Bleeding On A Thienopyridine
NCT01152229 ·Status: COMPLETED
-
A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease
NCT05193201 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness
NCT06792019 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP
NCT03102593 ·Status: COMPLETED ·Phase: PHASE2
-
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
NCT01933035 ·Status: COMPLETED
-
The Plasma Large-Volume Exchange RCT
NCT01433003 ·Status: WITHDRAWN ·Phase: PHASE3